Ribbesbuettel, Germany

Johann Gruenefeld

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Technische Universitat Braunschweig, Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Johann Gruenefeld. Retrieved from https://idiyas.com/inventor/johann-gruenefeld

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Johann Gruenefeld: Innovator in Antiprotozoal Compounds

Introduction

Johann Gruenefeld is a notable inventor based in Ribbesbuettel, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antiprotozoal activity. His work has implications for the treatment of diseases caused by parasites, including malaria.

Latest Patents

Gruenefeld holds a patent for "Indole compounds having antiprotozoal activity and its use as well as methods for producing the same." This invention focuses on new bisindolylcyclobuten-dione-based structures that exhibit antiprotozoal properties. The patent outlines pharmaceutical compositions containing these compounds and their application in the prophylaxis and treatment of parasite-based diseases, including malaria. Additionally, it provides methods for treating such diseases.

Career Highlights

Throughout his career, Gruenefeld has worked with esteemed institutions, including Technische Universitaet Braunschweig. His research has contributed to advancements in pharmaceutical sciences, particularly in the area of antiprotozoal treatments.

Collaborations

Gruenefeld has collaborated with notable colleagues such as Conrad Kunick and Hoang Lande. These partnerships have likely enhanced the scope and impact of his research efforts.

Conclusion

Johann Gruenefeld's innovative work in developing antiprotozoal compounds represents a significant advancement in the fight against parasitic diseases. His contributions continue to influence the pharmaceutical industry and improve treatment options for affected individuals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…